Henry studied biochemistry at the University of Bristol and completed his Ph.D. in Prof Wyatt Yue’s Lab at the Structural Genomics Consortium, University of Oxford. The focus of his Ph.D. was to use combinatorial structural approaches to characterise enzymatic complexes associated with rare inborn errors of metabolism. In 2021 he has joined the ‘ProxiDrugs’ consortium applying structure guided drug discovery methods to advance development of proximity inducing therapeutics.